← Open Payments lookup

JAMILA WHEELER-SMITH: Open Payments

NPI 1730645169 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,527 in 48 payments from 9 companies in 2025. Trend: 2023 $648 · 2024 $582 · 2025 $1,527

Food & beverage: $1,416Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$452
E.R. Squibb & Sons, L.L.C.6$306
ABBVIE INC.7$276
Neurocrine BioSciences, Inc.11$212
Alkermes, Inc.4$104
Otsuka America Pharmaceutical, Inc.3$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
Janssen Pharmaceuticals, Inc1$25
Axsome Therapeutics, Inc.1$13

Products named: UZEDY, COBENFY, VRAYLAR, INGREZZA, ARISTADA, CAPLYTA, LYBALVI, ABILIFY MAINTENA.

Industry payments across TX — which companies pay providers there.